Followers | 283 |
Posts | 1162 |
Boards Moderated | 0 |
Alias Born | 10/04/2020 |
![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, October 09, 2020 12:24:18 AM
Yes, I definitely discern this Company merged is way under-valued especially when one considers the exclusive Patent they own on their combined technologies and the multiple infectious disease viral vaccine applications associated with it.
Well established BigPharma players could cut a deal with Enz-BioClonetics to mass produce their drug for immediate commercial use in the near future, like you said, by licensing their Patent which by itself is worth Mega-Millions in immediate royalty revenues that will show up in the Quarterly Earnings Reports reflected in its Market Cap.
This would be a game changer and it's definitely the "fast-track" approach that could transform their company literally over night post-merge into a major player in BigPharma! Many doors will open for them as a result.
I believe the Merger itself has the potential to kick-up the PPS into the DOLLAR trading range but still on the OTC.
If fast track commercialization begins via BigPharma partners, the PPS will rapidly rise with transition to one of the major exchanges and its Market Cap will explode!
How long that will take is anyone's guess.
Recent ENZC News
- Small Cap Recipient of Military Drone Technology • InvestorsHub NewsWire • 11/20/2023 01:14:45 PM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM